Supplementary Figure 2 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial

L. Collet; Maude Ardin; David Venet; Justine Berthet; Sarah Barrin; Isabelle Treilleux; Jean‐Christophe Noël; Marianne Leheurteur; Jérôme Meunier; Leïla Bengrine-Lefèvre; Mathilde Martinez; Frank Priou; Frédèric Selle; Pierre-Alexandre Just; Guillaume Bataillon; Françoise Rothé; Christos Sotiriou; Christophe Caux; Bertrand Dubois; Isabelle Ray‐Coquard; Olivia Le Saux

doi:10.1158/1078-0432.29760208

Key Points

MAIN FINDING: The study reveals critical insights about pd-l1 expression and the tumor microenvironment in high-grade serous ovarian cancer.
KEY EVIDENCE: The flow chart presents the analyzed population, emphasizing the diverse tissue types examined during the trial.
APPROACH: The analysis was conducted within the framework of a Phase II randomized trial, focusing on biomarkers related to ovarian cancer.
SIGNIFICANCE: Understanding the tumor microenvironment can improve treatment strategies for patients with high-grade serous ovarian cancer.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Flow chart details analyzed biomarkers in high-grade serous ovarian cancer patients from a Phase II trial, indicating significant insights into tissue types.

Abstract

Supplementary Figure 2. Flow chart of the biomarkers analyzed population.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Collet et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d0221 https://doi.org/10.1158/1078-0432.29760208

View Full Paper

Ask AI

Bookmark

Share

Supplementary Figure 2 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Supplementary Figure 2 from Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading